Bone Morphogenetic Proteins in Lumbar Arthrodesis: What Is All the Debate About? Commentary on an article by Daniel C. Beachler, PhD, MHS, et al.: "Bone Morphogenetic Protein Use and Cancer Risk Among Patients Undergoing Lumbar Arthrodesis: A Case-Cohort Study Using the SEER-Medicare Database". - Suppr | 超能文献

Bone Morphogenetic Proteins in Lumbar Arthrodesis: What Is All the Debate About? Commentary on an article by Daniel C. Beachler, PhD, MHS, et al.: "Bone Morphogenetic Protein Use and Cancer Risk Among Patients Undergoing Lumbar Arthrodesis: A Case-Cohort Study Using the SEER-Medicare Database".

作者信息

Singh Kern, Massel Dustin H, Mayo Benjamin C, Bohl Daniel D, Long William W, Modi Krishna D

机构信息

Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, Illinois.

出版信息

J Bone Joint Surg Am. 2016 Jul 6;98(13):e57. doi: 10.2106/JBJS.16.00316.

DOI:10.2106/JBJS.16.00316

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Bone Morphogenetic Proteins in Lumbar Arthrodesis: What Is All the Debate About? Commentary on an article by Daniel C. Beachler, PhD, MHS, et al.: "Bone Morphogenetic Protein Use and Cancer Risk Among Patients Undergoing Lumbar Arthrodesis: A Case-Cohort Study Using the SEER-Medicare Database".

J Bone Joint Surg Am. 2016 Jul 6;98(13):e57. doi: 10.2106/JBJS.16.00316.

2

Bone Morphogenetic Protein Use and Cancer Risk Among Patients Undergoing Lumbar Arthrodesis: A Case-Cohort Study Using the SEER-Medicare Database.腰椎融合术患者中骨形态发生蛋白的使用与癌症风险：一项使用监测、流行病学和最终结果-医疗保险数据库的病例队列研究

J Bone Joint Surg Am. 2016 Jul 6;98(13):1064-72. doi: 10.2106/JBJS.15.01106.

3

Six-year outcomes of anterior lumbar interbody arthrodesis with use of interbody fusion cages and recombinant human bone morphogenetic protein-2.使用椎间融合器和重组人骨形态发生蛋白-2行腰椎前路椎间融合术的6年随访结果

J Bone Joint Surg Am. 2009 May;91(5):1181-9. doi: 10.2106/JBJS.G.01485.

4

Recombinant human bone morphogenetic protein-2: what's a spine surgeon to do?: commentary on an article by J. Michielsen, MD, et al.: "The effect of recombinant human bone morphogenetic protein-2 in single-level posterior lumbar interbody arthrodesis".

J Bone Joint Surg Am. 2013 May 15;95(10):e72. doi: 10.2106/JBJS.M.00124.

5

Cancer risk from bone morphogenetic protein exposure in spinal arthrodesis.脊柱融合术中骨形态发生蛋白暴露的癌症风险。

J Bone Joint Surg Am. 2014 Sep 3;96(17):1417-22. doi: 10.2106/JBJS.M.01190.

6

The effect of platelet-rich plasma and bone marrow on murine posterolateral lumbar spine arthrodesis with bone morphogenetic protein.富含血小板血浆和骨髓对小鼠腰椎后外侧融合联合骨形态发生蛋白的影响

J Bone Joint Surg Am. 2009 May;91(5):1199-206. doi: 10.2106/JBJS.G.01375.

7

Lumbar interbody fusion with utilization of recombinant human bone morphogenetic protein: a retrospective real-life study about 277 patients.利用重组人骨形态发生蛋白进行腰椎椎间融合术：一项关于277例患者的回顾性真实病例研究。

Neurosurg Rev. 2018 Jan;41(1):189-196. doi: 10.1007/s10143-017-0834-z. Epub 2017 Mar 10.

8

Recent article by Shields et al titled "adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion".希尔兹等人近期发表的一篇文章，标题为“颈椎前路融合术中高剂量重组人骨形态发生蛋白-2使用相关的不良反应” 。

Spine (Phila Pa 1976). 2006 Aug 1;31(17):2029-30. doi: 10.1097/01.brs.0000229387.20297.b1.

9

Role of Recombinant Human Bone Morphogenetic Protein-2 on Hindfoot Arthrodesis.重组人骨形态发生蛋白-2在后足关节融合术中的作用

Foot Ankle Clin. 2016 Dec;21(4):793-802. doi: 10.1016/j.fcl.2016.07.001.

10

Blood serum antibody analysis and long-term follow-up of patients treated with recombinant human bone morphogenetic protein-2 in the lumbar spine.血清抗体分析及经腰椎应用重组人骨形态发生蛋白-2 治疗患者的长期随访。

Spine (Phila Pa 1976). 2011 Dec 1;36(25):2158-67. doi: 10.1097/BRS.0b013e3182059a8c.

引用本文的文献

1

Bone morphogenetic protein-2 exhibits therapeutic benefits for osteonecrosis of the femoral head through induction of cartilage and bone cells.骨形态发生蛋白-2通过诱导软骨细胞和骨细胞，对股骨头坏死具有治疗作用。

Exp Ther Med. 2018 May;15(5):4298-4308. doi: 10.3892/etm.2018.5941. Epub 2018 Mar 9.